Regulatory partners determine whether a signal sustains or ends fibroblast contraction

Fibroblast

A cell that produces and reshapes material around cells. Fibroblasts can occupy different functional states; the name does not identify one fixed level of contraction or cell multiplication.

Yes-associated protein (YAP)

A protein involved in regulating gene activity and cellular responses to mechanical surroundings. This question concerns whether increasing or decreasing its activity helps end contraction; its amount, location, and activity are related measurements but are not interchangeable.

Transcriptional coactivator with PDZ-binding motif (TAZ)

A gene-regulating protein studied alongside YAP. Several supplied experiments suppress both proteins, so their results do not isolate the effect of suppressing YAP alone; the full name includes a label for a protein-binding feature.

Post-closure

The period after a wound has closed. Closure does not, by itself, establish that tissue movement or internal repair has returned to normal; the supplied material gives no specific duration for this period.

Contraction, mobility, and recoil

Contraction is tissue tightening caused by cellular pulling; mobility is the ability of tissue to move; recoil is its ability to spring back after deformation. They are distinct outcomes, so less contraction does not by itself demonstrate restored mobility or recoil.

Extracellular matrix

The material surrounding cells, which cells can produce, pull against, and reshape. Its mechanical properties form part of the surroundings tested in the supplied studies.

Matrix tension, stretch, and stiffness

Tension is pulling force carried by the surrounding material, stretch describes its deformation, and stiffness describes resistance to deformation. These are different properties, so evidence about stiffness does not automatically establish the effect of tension.

Fibrosis

Excessive accumulation of scar-like supporting material in tissue. Reducing fibrosis is one relevant outcome, but it does not alone establish recovered movement or lasting safety.

Senescence

A lasting cell state involving withdrawal from ordinary cell multiplication and changes in cell behavior. Senescence-associated measurements indicate features of that state; they do not by themselves establish all its consequences for tissue recovery.

Senescence-associated secretory phenotype (SASP)

A pattern of substances released by senescent cells that can include inflammatory signals. A reported SASP signature is a pattern of measurements associated with that behavior, rather than direct proof of later tissue recurrence.

Proliferation and proliferative persistence

Proliferation means cell multiplication. Persistence means that multiplication continues or returns when the desired repair response should have subsided.

Knockdown, inhibition, activation, and genetic removal

Knockdown reduces production of a target protein, inhibition reduces its function, and activation increases its activity. Genetic removal disables the gene supplying it; these interventions differ and cannot automatically be treated as equivalent.

Fibronectin and collagen

Proteins that form parts of the extracellular matrix. Fibronectin is the matrix component described as less stretched in S2, while collagen forms the experimental supports described for S4.

Alpha-smooth muscle actin

A protein associated with the cell’s contractile machinery. Its level serves as a marker of contractile cell state in S2, rather than a direct measurement of recovered tissue movement.

Nucleus and YAP location

The nucleus is the cell compartment containing its genetic material. The supplied studies distinguish YAP inside this compartment from YAP in the surrounding cell interior; location is not itself a measurement of contraction or safety.

Focal adhesion kinase (FAK)

A signaling protein involved in how cells respond through their attachments to surrounding material. S4 inhibits this protein and observes reduced remodeling alongside reduced YAP expression.

Hippo pathway

A system of signals involved in regulating YAP-related cell behavior. S9 concerns mouse heart fibroblasts with disrupted regulation in this system, which is a different manipulation from directly inhibiting YAP.

Engrailed-1 (En-1)

A gene-regulating factor whose activation is reported as prevented in S10. It is part of that source’s account of scarless repair, not a demonstrated explanation of recovery after closure.

Regeneration

Rebuilding damaged tissue. The question requires functional recovery as well as reduced scarring, so a report of regeneration does not automatically establish every outcome it asks about.

Engineered tissue-growth model

An experimentally constructed setting in which cells grow and organize tissue. S2 uses such a model, rather than examining an already-closed skin wound.

YAP has both contraction-promoting and regeneration-supporting activity; excessive inhibition may induce inflammatory senescence, and cell state, matrix tension, and timing can reverse which intervention direction supports persistent recovery.

YAP is a protein involved in how fibroblasts respond to their surroundings, and the matrix is the material those cells build and pull against. The assumption is that the same protein can sustain tightening or help rebuild tissue, while suppressing it too strongly can leave cells in a lasting, inflammation-associated state. If established, this would make the choice between activation and inhibition depend on the surrounding forces and the stage of repair.

Reduced contraction after combined YAP and related-protein suppression supports a contraction-promoting role [S1, S6]. Findings involving matrix stretch, stiffness, and YAP location support sensitivity to the mechanical surroundings, but do not establish a reversal in the preferred treatment direction [S2, S3, S6]. The supplied sources do not establish that excessive YAP inhibition causes inflammatory senescence or that YAP activation supports regeneration after closure. Instead, S10 reports regeneration associated with YAP inhibition, S7 reports benefits from fibroblast YAP removal in heart injury, and S9 reports senescence-associated changes in heart fibroblasts lacking a regulatory pathway. These findings challenge a general activation-benefit or inhibition-harm assumption without settling the specific skin question.S1S2S3S6S7S9S10

The same question asked without the part nothing read establishes:

• After skin wound closure, does activating or inhibiting fibroblast YAP better stop contraction and restore movement without senescence or persistent cell multiplication?
• Does tension in the material surrounding fibroblasts change the effects of YAP activation or inhibition on contraction and lasting recovery after skin wound closure?

• Activation produces safer, lasting recovery If activation stops contraction while preserving movement and avoiding the specified harmful cell states, YAP activity would support recovery in that post-closure setting. Suppression could then interfere with that recovery, even though suppression reduces contraction in other supplied laboratory settings.
• Inhibition produces safer, lasting recovery If inhibition reduces cell-generated pulling and movement recovers without senescence or returning cell multiplication, continued YAP activity would be sustaining the unwanted state in that setting. Activation could then prolong tightening instead of ending it.
• The safer direction depends on surrounding tension If different tension conditions favor opposite interventions, the surroundings would determine whether activation or inhibition ends contraction with lasting functional recovery. Applying one direction across those conditions could improve one tissue state while sustaining contraction or harmful cell behavior in another.
• Neither direction produces the required recovery An intervention could reduce contraction while leaving movement impaired or allowing harmful cell states to persist. In that case, changing YAP alone would not meet the question’s combined requirement for function, safety, and persistence after withdrawal.

Fibroblasts can change the material surrounding them and generate contraction, so changing their activity could affect both wound tightening and later tissue movement. In the supplied laboratory evidence, reducing YAP together with a related protein reduces contraction, with one source reporting this effect specifically on abnormally stiff material [S1, S6]. However, reduced contraction alone does not establish recovered movement, spring-back, or freedom from harmful lasting cell states. Treating those outcomes as interchangeable could mistake an immediate reduction in pulling for durable recovery. Conversely, assuming that activation supports regeneration could overlook the reported benefits of YAP removal in injured heart tissue and the senescence-related findings in a separate heart-cell study [S7, S9].